Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Human papillomavirus and cervical cancer.

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.

Lancet. 2007 Sep 8;370(9590):890-907. Review.

PMID:
17826171
2.
3.

Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?

Castle PE.

Am J Epidemiol. 2008 Jul 15;168(2):138-44; discussion 145-8. doi: 10.1093/aje/kwn037. Epub 2008 May 15.

4.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
5.

Human papillomavirus infection and cervical cancer prevention in Japan and Korea.

Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.

Vaccine. 2008 Aug 19;26 Suppl 12:M30-42. doi: 10.1016/j.vaccine.2008.05.006.

PMID:
18945412
6.

Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.

Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W; RIS HPV TT Study Group.

J Pathol. 2012 Dec;228(4):534-43. doi: 10.1002/path.4065.

PMID:
22711526
7.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.

Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.

PMID:
21865084
9.

Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.

Harper DM.

Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S11-7. doi: 10.1016/j.ygyno.2008.06.029. Epub 2008 Jul 22.

PMID:
18649932
10.

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.

Darwich L, Cañadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernández I, Llatjós M, Coll J, Clotet B, Videla S.

Int J Gynecol Cancer. 2011 Nov;21(8):1486-90. doi: 10.1097/IGC.0b013e31822a0195.

PMID:
21892092
11.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

Cancer. 2008 Oct 1;113(7 Suppl):1980-93. doi: 10.1002/cncr.23704. Review.

12.

Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.

Vlădăreanu R, Andrei C.

Rev Med Chir Soc Med Nat Iasi. 2007 Jan-Mar;111(1):144-54. Review.

PMID:
17595860
13.

Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.

[No authors listed]

Prescrire Int. 2008 Jun;17(95):103-4.

PMID:
18623911
14.

[Human papillomavirus prophylactic vaccines: stakes and perspectives].

Hantz S, Alain S, Denis F.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. Epub 2006 Jun 27. Review. French.

PMID:
16807045
15.
16.

New advances in vaccine technology and improved cervical cancer prevention.

Huh WK, Kendrick JE, Alvarez RD.

Obstet Gynecol. 2007 May;109(5):1187-92.

PMID:
17470604
17.

Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.

Cox JT.

Baillieres Clin Obstet Gynaecol. 1995 Mar;9(1):1-37. Review.

PMID:
7600720
18.

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD.

J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001. Epub 2010 Feb 15.

19.

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.

Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.

Vaccine. 2008 Aug 19;26 Suppl 12:M80-8. doi: 10.1016/j.vaccine.2008.05.041.

PMID:
18945417
20.

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.

PLoS Med. 2006 May;3(5):e138. Epub 2006 Apr 4.

Supplemental Content

Support Center